All Clinical Trials
Below is a list of all clinical trials, conducted by several of our specialty service lines. You may filter the list of trials by clicking the "Department" dropdown menu and selecting the area that you want to view or that pertains to you.
Clicking "Learn More" may either take you to more information about our departments that conduct the research, or to the official clinicaltrials.gov page for more information about the trial.
NRG-BN013, Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) versus Fractionated SRS (FSRS) for Intact Brain Metastases
Study # NRG-BN013 Date Opened: 12/12/2024 Closing Date: 06/30/2028 Principal Investigator: David Perry, M.D. Sponsor: NRG Oncology
NRG-GI011: A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)
Study # NRG-GI011 Date Opened: 07/15/2025 Closing Date: 10/21/2030 Principal Investigator: David Perry, M.D. Sponsor: NRG Oncology
A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack (L
Study # NCT05702034 Date Opened: 02/15/2023 Closing Date: 12/09/2026 Principal Investigator: Jennifer Berkeley, MD, PhD Sponsor: Janssen Research & Development
EXActDNA-003: Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated with Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease (Exact 2023-05 / NSABP B-64)
Study # 2023-05
